These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28636622)

  • 21. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.
    Li B; Wang Y; Shen F; Wu M; Li Y; Fang Z; Ye J; Wang L; Gao L; Yuan Z; Chen J
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection.
    Vaillant A
    ACS Infect Dis; 2019 May; 5(5):675-687. PubMed ID: 30199230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
    J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.
    Moini M; Fung S
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
    Wang XJ; Hu W; Zhang TY; Mao YY; Liu NN; Wang SQ
    Antiviral Res; 2015 Aug; 120():140-6. PubMed ID: 26086883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes.
    Ying C; Van Pelt JF; Van Lommel A; Van Ranst M; Leyssen P; De Clercq E; Neyts J
    Antivir Chem Chemother; 2002 May; 13(3):157-64. PubMed ID: 12448688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells.
    Jia YY; Guan RF; Wu YH; Yu XP; Lin WY; Zhang YY; Liu T; Zhao J; Shi SY; Zhao Y
    Mol Med Rep; 2014 Apr; 9(4):1381-7. PubMed ID: 24481875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
    Watashi K; Sluder A; Daito T; Matsunaga S; Ryo A; Nagamori S; Iwamoto M; Nakajima S; Tsukuda S; Borroto-Esoda K; Sugiyama M; Tanaka Y; Kanai Y; Kusuhara H; Mizokami M; Wakita T
    Hepatology; 2014 May; 59(5):1726-37. PubMed ID: 24375637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.
    Al-Mahtab M; Bazinet M; Vaillant A
    PLoS One; 2016; 11(6):e0156667. PubMed ID: 27257978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle.
    Esser K; Lucifora J; Wettengel J; Singethan K; Glinzer A; Zernecke A; Protzer U
    Antiviral Res; 2018 Mar; 151():4-7. PubMed ID: 29309795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
    Schulze A; Mills K; Weiss TS; Urban S
    Hepatology; 2012 Feb; 55(2):373-83. PubMed ID: 21953491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.
    Lucifora J; Esser K; Protzer U
    Antiviral Res; 2013 Feb; 97(2):195-7. PubMed ID: 23266293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fibronectin on HBV infection in primary human fetal hepatocytes in vitro.
    Wang F; Zhang X; Zhang J; Hui L; Wang Y; Wang X
    Mol Med Rep; 2012 Nov; 6(5):1145-9. PubMed ID: 22895745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive biomarkers for chronic hepatitis B virus infection management.
    Charre C; Levrero M; Zoulim F; Scholtès C
    Antiviral Res; 2019 Sep; 169():104553. PubMed ID: 31288041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.